Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05388669 |
|---|---|
| Brief Title: | A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer (PALOMA-3) |
| First Submitted : | May 19, 2022 |
| First Submitted that Met QC Criteria : | May 19, 2022 |
| First Posted : | May 24, 2022 |
| Last Update Submitted that Met QC Criteria : | January 29, 2024 |
| Last Update Posted : | January 31, 2024 |